📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Novel tRNA synthetase inhibitors to treat drug resistant Gram-negative infections

Lead Participant: OXFORD DRUG DESIGN LIMITED

Abstract

Awaiting Public Project Summary

Lead Participant

Project Cost

Grant Offer
OXFORD DRUG DESIGN LIMITED £1,980,007 £ 1,980,007

Publications

10 25 50